MedTrace Logo

Is Myopathy Part of Statin Therapy (IMPOSTER-16)

NCT00127335 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2022-11-23

No results posted yet for this study

Summary

There is a significant proportion of patients complaining of muscle symptoms while on statin therapy who have a measurable difference in muscle strength or endurance and whose muscle biopsies are diagnostic for myopathy.

Conditions

  • Myopathic Conditions

Interventions

DRUG

cellulose placebo vs. atorvastatin

drug

Sponsors & Collaborators

  • Scripps Health

    lead OTHER

Principal Investigators

  • Paul S Phillips, MD · Scripps Health

  • Harminder Sikand, PharmD · Scripps Mercy

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-08-31
Primary Completion
2008-05-31
Completion
2008-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00127335 on ClinicalTrials.gov